Dendritic Cell Vaccination

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer
Harm Westdorp, Jeroen H. A. Creemers, Inge M. van Oort, Gerty Schreibelt, Mark A. J. Gorris, Niven Mehra, Michiel Simons, Anna L. de Goede, Michelle M. van Rossum, Alexandra J. Croockewit, Carl G. Figdor, J. Alfred Witjes, Erik H. J. G. Aarntzen, Roel D. M. Mus, Mareke Brüning, Katja Petry, Martin Gotthardt, Jelle O. Barentsz, I. Jolanda M. de Vries, Winald R. Gerritsen

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 302; DOI: 10.1186/s40425-019-0787-6
Preliminary association of circulating tumor cells (CTCs) pre- and post-AdHER2 dendritic cell vaccination with overall survival in patients with metastatic HER2+ solid tumors
Yusuke Tomita, Jane Trepel, Min-Jung Lee, Sunmin Lee, Jay A Berzofsky, Lauren V Wood

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P179; DOI: 10.1186/2051-1426-3-S2-P179
Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients
Kalijn Bol, Thomas van den Bosch, Gerty Schreibelt, Cornelis Punt, Carl Figdor, Dion Paridaens, Jolanda de Vries

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P127; DOI: 10.1186/2051-1426-3-S2-P127
Autologous whole-tumor antigen vaccination in combination with adoptive T cell therapy for patients with recurrent ovarian cancer
Lana E Kandalaft, Cheryl Chiang, Emese Zsiros, Janos Tanyi, Daniel Powell, Rosemarie Mick, George Coukos

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P220; DOI: 10.1186/2051-1426-1-S1-P220
Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo
Carina Wehner, Christian Ellinger, Silke Raffegerst, Susanne Wilde, Barbara Mosetter, Dolores J Schendel, Slavoljub Milosevic

Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P239; DOI: 10.1186/2051-1426-1-S1-P239
P55. Dendritic cell vaccination for postremission therapy in AML
FS Lichtenegger, B Beck, I Bigalke, C Geiger, W Hiddemann, R Henschler, G Kvalheim, DJ Schendel, M Subklewe

Journal for ImmunoTherapy of Cancer Mar 2014, 2 (Suppl 2) P29; DOI: 10.1186/2051-1426-2-S2-P29
P10. Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8+ T cell and B cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
C Bauer, A Sterzik, F Bauernfeind, P Duewell, C Conrad, R Kiefl, S Endres, A Eigler, M Schnurr, M Dauer

Journal for ImmunoTherapy of Cancer Mar 2014, 2 (Suppl 2) P1; DOI: 10.1186/2051-1426-2-S2-P1

Log in using your username and password

Main menu

Log in using your username and password

You are here

Dendritic Cell Vaccination